Poland· PL-100487897
Miofree
A atropine product containing atropini sulfas, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Atropine is registered in 13 of 19 countries.
Countries holding a registration under ATC S01FA01 (atropine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Atropine · ATC S01FA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Atropini sulfas
- Manufacturer
- Zakłady Farmaceutyczne POLPHARMA S.A.
- Country
- Poland (PL)
- ATC code
- S01FA01
- ATC class
- Atropine
- Defined daily dose
- 1 mg, AT
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05903060631489
- gtin05903060631496
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
14 interactions on record for atropine.
Graded by severity as the source publishes them — 14 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atropine · interactions on record
14 records
- 14 moderate
Most severe, free to view
- PhenylephrineC01CA06moderate
- TacrineN06DA01moderate
- DonepezilN06DA02moderate
- RivastigmineN06DA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Atropine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRYJUNEASanten OY, Tampere
- FinlandRyjuneaSanten Oy
- IrelandRyjunea 0.1 mg/ml eye drops, solutionSanten OY
- IcelandRyjuneaSanten Oy*
- NetherlandsRyjunea 0,1 mg/ml oogdruppels, oplossingSanten Oy
- NorwayRyjuneaSanten Oy
- BelgiumRyjunea 0.1 mg/mlSanten
- SwedenRyjunea 0,1 mg/ml Ögondroppar, lösningSanten Oy
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Atropin Accord, Atropinsulfat Aguettant
- Belgium · Atropine Alcon, Atropine Sulfate Aguettant
- Bulgaria · Атропин Вижън, Атропин Софарма
- Cyprus · Atropine Sulfate, Atropine Αρητη
- Czechia · Atropin Bbp, Atropin-Pos
- Germany · Atropin Accord, Atropin-Pos
- Denmark · Atropin Abboxia, Atropin Aguettant
- Estonia · Atropine Auxilia, Atropine Basi
- Spain · Atropina Accord, Atropina Aguettant
- Finland · Atropin Abboxia, Atropin Aguettant
- France · Atropine (Sulfate) Aguettant, Atropine (Sulfate) Pharmacie Centrale Des Armees
- United Kingdom (Northern Ireland) · Atrophine Sulfate Wockhardt Uk, Atropine Aspire
- Greece · Atropine Sulfate Bradex, Atropine Sulfate Cooper
- Hungary · Atropine Sulphate Noridem, Atropinum Sulfuricum Egis
- Ireland · Atropine Sulfate Aguettant, Minims
- Iceland · Atropin Abboxia, Atropin Viatris
- Italy · Atropina Farmigea, Atropina Solfato Accord
- Liechtenstein · Ryjunea
- Lithuania · Atropine Sulfate Basi
- Luxembourg · Alcon, Atropine (Sulfate) Noridem
- Latvia · Atropine Sopharma, Atropine Sulfate Basi
- Malta · Minims
- Netherlands · Atorvastatina Cf, Atropinesulfaat Accord
- Norway · Atropin Abboxia, Atropin Aguettant
- Portugal · Atropina Accord, Atropina Aguettant
- Romania · Sulfat De Atropină Accord, Sulfat De Atropină Evolan
- Sweden · Atropin Abboxia, Atropin Aguettant
- Slovakia · Atropin Bbp, Atropine Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/292bc1bb-5f61-4472-87ee-6999469eea84 GET /v1/drugs/292bc1bb-5f61-4472-87ee-6999469eea84?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "100 mcg/ml",
"packaging": "05903060631489 ¦ Rp ¦ 161235\n1 butelka 2,5 ml\n05903060631496 ¦ Rp ¦ 161236\n1 butelka 7,5 ml",
"substance": "Atropini sulfas 0.1 mg/ml",
"common_name": "Atropini sulfas",
"pl_product_id": "100487897",
"pozwolenie_nr": "28967",
"auth_procedure": "NAR",
"authorisation_validity": "2030-04-30"
}See everything about atropine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.